Vigilare Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Vigilare Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-441	Closed	-$230K	–	94
2023 Q2	$230K	Sell	441 -10	-2%	-$5.4K	0.13%	86
2023 Q1	$260K	Sell	451 -50	-10%	-$28.2K	0.15%	80
2022 Q4	$276K	Sell	501 -10	-2%	-$5.3K	0.16%	80
2022 Q3	$259K	Hold	511	–	–	0.34%	75
2022 Q2	$278K	Sell	511 -370	-42%	-$204K	0.3%	80
2022 Q1	$520K	Buy	881 +415	+89%	+$238K	0.43%	59
2021 Q4	$311K	Hold	466	–	–	0.18%	135
2021 Q3	$266K	Hold	466	–	–	0.16%	158
2021 Q2	$235K	Sell	466 -15	-3%	-$7.08K	0.14%	178
2021 Q1	$220K	Hold	481	–	–	0.16%	168
2020 Q4	$224K	Buy	+481	New	+$226K	0.21%	119

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vigilare Wealth Management's TMO Position: Q3 2023 in Review

Vigilare Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 441 shares — an estimated $230K sold.

Vigilare Wealth Management first reported a position in TMO in Q4 2020 and held it in 11 quarters. The position peaked at $520K in Q1 2022. 2,365 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

Vigilare Wealth Management reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
Vigilare Wealth Management sold 441 Thermo Fisher Scientific shares in Q3 2023, an estimated $230K.
Vigilare Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 11 quarters.
Vigilare Wealth Management's Thermo Fisher Scientific position peaked at $520K in Q1 2022.
2,365 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Vigilare Wealth Management's 13F filing for Q3 2023, filed 10 Oct 2023.